Exelixis $EXEL Monthly Outlook$EXEL run %54 so far on this month. It is very close to pivot. Expect to pull back to form the handle
Healthcare
Gilead in tested channelGILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir.
Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance.
A close below the 50sma would change the sentiment, and remove us from the channel.
$CUTR can fall in the next daysContextual immersion trading strategy idea.
Cutera is a medical device company, which designs, develops, manufactures, markets, and services laser and other energy-based aesthetics systems.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price in the next days.
So I opened a short position from $10,78;
stop-loss — $11,26.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$SGRY can rise in the next daysContextual immersion trading strategy idea.
Surgery Partners, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $9,60;
stop-loss — $8,99.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Simulations Plus #SLPSimulations Plus has been performing very well since mid of march is breaking out the pivot.
Emergent BioSolutions Emergent BioSolutions is trying to break $71.19. RSI is below the trend and volume is not enough yet to get over
BioSig Technologies $BSGM#BioSigTechnologies hit the last high yesterday. The volume is above the average. RSI is moving up.
$AXGN can fall in the next daysContextual immersion trading strategy idea.
AxoGen provides surgical solutions for physical damage or transection to peripheral nerves.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price in the next days.
So I opened a short position from $7,22;
stop-loss — $7,84.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$CODX can rise in the next daysContextual immersion trading strategy idea.
Co-Diagnostics is a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests.
Due to the spread of COVID-19, the demand for the company`s services rose.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $13,31;
stop-loss — $12,62.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Alnylam Pharmaceuticals $ALNY#AlnylamPharmaceuticals just hit the strong resistance. Volume is above the average but RSI is below the trendline. Negative divergence is on weekly
Short by put option from to weekly level support $102Short by put option from to weekly level support $102
Biod Rad Laboratories $BIO$BIO just broke the pivot but RSI is still below the trend. It may stall on nextweek.
INCYTE Corp $INCYINCY broke the resistance with great volume. After long rally, it is maybe time to pull back. Watch for RSI
$CDTX can rise in the next daysContextual immersion trading strategy idea.
Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases
The demand for shares of the company looks higher than the supply.
Due to the spread of COVID-19, the demand for the company`s services rose.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $2,82;
stop-loss — $2,59.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
InfuSystem Holdings $INFU#InfuSystem Holdings hit the resistance. Volume is still low and needs to be strength to continue
Masimo Corporation $MASIIt broke out with super volume and doesnt seem to stop. Just watch RSI resistance
Amedisys $AMED#Amedisys has just broke out the top yesterday with good volume and likely will continue today.
